Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 640

1.
2.

Recent changes in practice of elective percutaneous coronary intervention for stable angina.

Ahmed B, Dauerman HL, Piper WD, Robb JF, Verlee MP, Ryan TJ Jr, Goldberg D, Boss RA Jr, Phillips WJ, Fedele F, Butzel D, Malenka DJ; Northern New England Cardiovascular Disease Study.

Circ Cardiovasc Qual Outcomes. 2011 May;4(3):300-5. doi: 10.1161/CIRCOUTCOMES.110.957175. Epub 2011 Apr 19.

3.

Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.

Teo KK, Sedlis SP, Boden WE, O'Rourke RA, Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators.

J Am Coll Cardiol. 2009 Sep 29;54(14):1303-8. doi: 10.1016/j.jacc.2009.07.013.

4.

Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.

Maron DJ, Spertus JA, Mancini GB, Hartigan PM, Sedlis SP, Bates ER, Kostuk WJ, Dada M, Berman DS, Shaw LJ, Chaitman BR, Teo KK, O'Rourke RA, Weintraub WS, Boden WE; COURAGE Trial Research Group.

Am J Cardiol. 2009 Oct 15;104(8):1055-62. doi: 10.1016/j.amjcard.2009.05.056. Epub 2009 Aug 28.

PMID:
19801024
5.

Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.

Holper EM, Addo T.

Coron Artery Dis. 2010 Nov;21(7):397-401. doi: 10.1097/MCA.0b013e32833d0134. Review.

PMID:
20634692
6.

Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.

Maron DJ, Boden WE, O'Rourke RA, Hartigan PM, Calfas KJ, Mancini GB, Spertus JA, Dada M, Kostuk WJ, Knudtson M, Harris CL, Sedlis SP, Zoble RG, Title LM, Gosselin G, Nawaz S, Gau GT, Blaustein AS, Bates ER, Shaw LJ, Berman DS, Chaitman BR, Weintraub WS, Teo KK; COURAGE Trial Research Group.

J Am Coll Cardiol. 2010 Mar 30;55(13):1348-58. doi: 10.1016/j.jacc.2009.10.062.

7.

Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators.

Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, Forman SA, Geller NL, Goldberg AD, Habib GB, et al.

J Am Coll Cardiol. 1995 Sep;26(3):594-605.

8.

COURAGE under fire: on the management of stable coronary disease.

Diamond GA, Kaul S.

J Am Coll Cardiol. 2007 Oct 16;50(16):1604-9. Epub 2007 Sep 17.

9.

Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE; COURAGE Investigators.

Circulation. 2008 Mar 11;117(10):1283-91. doi: 10.1161/CIRCULATIONAHA.107.743963. Epub 2008 Feb 11.

10.

Interpreting the results of the COURAGE trial: a non-interventionalist perspective.

Boden WE.

Rev Cardiovasc Med. 2009;10 Suppl 2:S34-44. Review.

PMID:
19898280
11.

Medical therapy after successful percutaneous coronary revascularization.

Hasdai D, Lerman A, Grill DE, Rihal CS, Holmes DR Jr.

Ann Intern Med. 1999 Jan 19;130(2):108-15.

PMID:
10068356
13.

Optimal medical therapy is a proven option for chronic stable angina.

O'Rourke RA.

J Am Coll Cardiol. 2008 Sep 9;52(11):905-7. doi: 10.1016/j.jacc.2008.06.015.

14.

Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).

Boden WE, O'Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada M, Labedi M, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators.

Am J Cardiol. 2009 Jul 1;104(1):1-4. doi: 10.1016/j.amjcard.2009.02.059. Epub 2009 Apr 16.

PMID:
19576311
15.

[Aggressive medical therapy for stable coronary disease: with or without percutaneous coronary intervention (COURAGE trial)].

Manigold T, Gosselin G.

Rev Med Suisse. 2008 May 28;4(159):1332-4, 1337. Review. French.

PMID:
18592725
17.
18.
19.

Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.

Kiernan TJ, Prasad A, Gersh BJ.

Rev Cardiovasc Med. 2007 Fall;8(4):234-9. Review. No abstract available.

PMID:
18192947
20.

Trials and tribulations associated with angina and traditional therapeutic approaches.

Deedwania PC, Carbajal EV, Bobba VR.

Clin Cardiol. 2007 Feb;30(2 Suppl 1):I16-24. Review.

Supplemental Content

Support Center